Table 2.
Indirect regulatory efficacy of Chinese medicines on NF-κB pathway
Classifications | Chinese medicines | Models | Mechanisms | References |
---|---|---|---|---|
Heat-clearing and dampness-drying medicine | Casticin | RAW264.7 | Down-regulate the phosphorylation of AKT, thus down-regulate the phosphate kinase activity of IKKα/β, thereby failing to phosphorylate IκBα | [44] |
Baicalin | DSS-induced colon tissue | Reduce the protein levels of p-IκB-α, whereas IκB-α protein expression is increased | [45] | |
UC patients | Increase p-STAT6/STAT6 ratio, but decrease ratios of p-STAT4/STAT4 | [46] | ||
Wogonin | Caco-2 cells | Decrease phosphorylation and degradation of IκB; inhibit the expression of TLR4, MyD88 and TAK1 | [47] | |
Wogonoside | DSS-induced colon tissues | Inhibit phosphorylated IκBα | [48] | |
AOM/DSS-induced tumor tissues | Decrease the phosphorylation of IKKα and IκBα, inhibit NF-κB activation via PI3K/Akt pathway | [49] | ||
THP-1 cells | Inhibit phosphorylation of IKKα and IκBα | [49] | ||
Berberine | Colonic macrophages | Inhibit ERK1/2, p38, and JNK activation; inhibit IκB degradation | [50] | |
Colonic epithelial cells | Decrease IκB degradation and ERK1/2 and p38 activation | [50] | ||
Berberine hydrochloride | DSS-induced colonic tissues | Suppress the expressions of phosphorylation of STAT3; inhibit the activation of IL-6/STAT3/NF-κB | [54, 55] | |
Apocynin | DSS-induced tissues | Reduce the activation of STAT3 | [56] | |
SM934 | DSS-induced colon tissue | Decrease phosphorylation of IκB; abrogate the increased phosphorylation of ERK1/2 induced by DSS | [61] | |
Interior-warming and drying dampness medicine | Aesculin | RAW264.7 cells | Suppress the phosphorylation of IκBα | [65] |
Total triterpenoids of Chaenomeles speciosa | DSS-induced colon tissue | Down-regulate the protein expressions of cytosol PPARγ, tissue p-IKKβ and p-IκBα, decrease the p-IKKβ/IKKβ and p-IκBα/IκBα ratios, up-regulate the protein expressions of nucleus PPARγ, tissue SIRT1 | [66] | |
Cardamonin | RAW264.7 cells | Inhibit phosphorylation and degradation of IκBα; inhibit p38 phosphorylation | [67] | |
3,4-Oxo-isopropylidene-shikimic acid | TNBS-induced colon tissues | Decrease the change of IκBα expression in the nucleus | [70] | |
Wu Zhu Yu | DSS-induced colonic tissues | Down-regulated the increased phosphorylation levels of IκB | [71] | |
Clove | DSS-induced colon tissues | Reduce the expressions of p-IκB-α | [73] | |
RAW264.7 macrophages | Decrease the expressions of p-IκB-α | [73] | ||
Zanthoxylum bungeanum | DSS-induced colon tissue | Inhibit IκBα phosphorylation levels; suppress NF-κB due to inhibition of TLR4 | [74] | |
Galangin | DSS-induced colon tissue | Suppress protein expressions of p-Ikk-βα; increase the expression level of phosphorylation of IκBα in the cytoplasmic fraction | [75] | |
Detoxificating and purgative medicine | Parthenolide | DSS-induced colon tissue | Inhibit IkB protein phosphorylation; block the phosphorylation and degradation of IκBα | [76] |
HCT116 cells | Inhibit the phosphorylation of IkB-α | [77] | ||
Arctigenin | DSS-induced colonic tissues | Suppress phosphorylation of IκBα | [78] | |
Andrographolide derivative AL-1 | TNBS-induced colon tissues | Aattenuate the expression levels of p-IκBα; increase the expression of PPAR-γ | [79] | |
Andrographolide derivative CX-10 | DSS-induced colonic tissue | Reduce the expressions of p-IκBα; increase the expression of IκBα and suppresses the phosphorylated p38MAPK, ERK and JNK | [80] | |
Brucea javanica oil | DSS-induced colon tissues | Inhibit the phosphorylation of IκBα | [82] | |
Total flavonoids of Hedyotis diffusa Willd | RAW 264.7 cells | Suppress IκB phosphorylation, and reduce the phosphorylation of MAPK | [83] | |
Qing Dai | RAW264.7 cells | Inhibit IkBα degradation | [86] | |
Indirubin | DSS-induced colon tissues | Reverse DSS-mediated up-regulation of p-IκBα and p-IKKα/β as well as down-regulation of IκBα and IKKα/β | [87] | |
Dandelion | DSS-induced NCM460 cell | Decrease the phosphorylation of Akt | [88] | |
Rhubarb-type anthraquinones | HT-29 cells | Emodin up-regulating the expression of IκB | [92] | |
Macrophages | Chrysophanol inhibit IκBα degradation | [93] | ||
Gallic acid | DSS-induced colon tissue | Attenuate the activation and nuclear accumulation of p-STAT3 (Y705); prevent the degradation of the inhibitory protein IκB | [94] | |
Allicin | DSS-induced colonic mucosa | Inhibit activation and nuclear accumulation of STAT3; prevent the inhibition of protein IκB degradation | [95] | |
Bergenin | RAW264.7 cells | Activate PPARγ, leading to increased expression of SIRT1 | [97] | |
Fagopyrum cymosum (Trev.) Meisn | RAW264.7 cells | Inhibit IκB phosphorylation | [98] | |
Chlorogenic acid | DSS-induced Colon Mucosa | Reduce the phosphorylation level of IκB; improve the expression of ERK1/2, p-ERK, p38, p-p38, JNK, and pJNK proteins of the MAPK/ERK/JNK pathway | [99] | |
Blood-activating medicine | Liriodendrin | DSS-induced colon tissues | Reduce in phosphorylation of Akt; Block the phosphorylation of IκBα | [101] |
RAW264.7 macrophages | Reduce the phosphorylation of IκBα | [101] | ||
Shikonin | DSS-induced colon tissues | Reduce the expression of pSTAT-3 | [102] | |
Tetramethylpyrazine | OXZ-induced colitis mucosa | Restore PPAR-γ expression; reverse increased p38 MAPK phosphorylation | [103] | |
(2)-epigallocatechin-3-gallate | IEC-6 cells | Inhibit the activation of IκB kinase | [106] | |
Curcumin | DSS-induced colonic tissue | Inhibit the activating signals of p38MAPK | [112] | |
Qi-regulating medicine | Norisoboldine | DSS-induced colon tissues | Repress the phosphorylations of p38MAPK and ERK | [113] |
Tonifying medicine | Eclipta Prostrata | HT-29 cells | Reduce the degradation of IκB | [115] |
Astragaloside IV | CCD‑18Co cells | Inhibit the phosphorylation of IκB | [117] | |
Licochalcone A | DSS-induced colonic tissues | Reverse the increased expression of IKKα and p-IκB | [118] | |
The fruit of Ziziphus jujuba Mill. | AOM/DSS-induced colon tissue | Attenuate inflammation, tumor development and progression by down-regulation of expression of STAT3 | [122] | |
Lentinus edodes β-glucans | DSS-induced colon tissues | Modify p38MAPK and ERK1/2, and then phosphorylating PPARγ, which negatively regulates activation of NF-κB | [124] | |
Mango polyphenolics | DSS-induced intestinal mucosa | Attenuate the levels of inflammatory markers via suppression of the PI3K/AKT/mTOR signaling pathway, in part through up-regulation of miRNA-126 | [125] | |
Astringent medicine | Ursolic acid | Macrophages | Inhibit the phosphorylation of IKKβ and IκBα; suppress MAPK signaling pathways | [129] |
Rubus coreanus | RAW264.7 macrophages | Block the IκBα phosphorylation and degradation of IκBα; suppression of MAPK activation | [130] | |
Osthole | DSS-induced colonic tissue | Reduce the expression of p-IκBα and increase IκBα expression | [132] | |
RAW 264.7 cells | Reduce the phosphorylation of the MAPK/p38 protein; Facilitate a full recovery of the degradated IκBα protein | [132] | ||
Tonifying Qi and activating blood category | Shen Ling Bai Zhu San | DSS-induced colonic tissue | MAPK and NF-κB pathways share crosstalk | [133] |
Tou Nong San | TNBS-induced colon tissue | Inhibit p65 mainly by inhibiting the phosphorylation of IKKβ and thus the degradation of IB | [134] | |
Heat-clearing and drying dampness category | Gegenqinlian decoction | DSS-induced colonic tissues | Decrease the P-IκB | [139] |
RAW 264.7 cells | Inhibit the degradation of IκB | [139] | ||
Jianpi Qingchang decoction | DSS‑induced colon tissue | Increase the expression of IκB | [140] | |
Qing Hua Chang Yin | DSS‑induced colon tissue | Inhibit the expression of the phosphorylation of IκB | [143] | |
Caco-2 cells | Suppress the phosphorylation of JAK1, JAK2 and STAT3 | [144] | ||
QingBai decoction | DSS-induced colon tissue | Strengthen mucus barrier through inhibiting p‐ERK and Notch signaling | [145] | |
Chang-An-Shuan | TNBS-induced colonic tissues | Reduce the levels of p38 and p-AKT proteins | [146] | |
Compound sophorae decoction | DSS‑induced colonic tissues | Suppress the activation of STAT3 | [149] | |
Huangkui Lianchang decoction | DSS-induced Colon Tissue | Decrease the IκBα and p-IκBα levels | [150] | |
Warming yang and drying dampness category | Modified ZenWu decoction | DSS-induced colonic tissues | Lessen the degradation of IκBα | [154] |
Ping weisan | DSS-induced colon tissues | Reduce phosphorylation of IκBα | [155] | |
RAW264.7cells | Reduce phosphorylation of IκBα | [155] | ||
Astringent category | Zhenrenyangzang decoction | TNBS-induced colon tissues | Attenuate the protein expression of IκB-α subunit and phosphorylated p38MAPK (p-p38MAPK) | [156] |